SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables of -$222K in Q1 FY2026

Q1 FY2026 accounts receivables was -$222K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$222K+1650.0% QoQ
Last fiscal yearDec 2025
-$8K— YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(8K) USD
Year-over-year change
—

Accounts Receivables vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Accounts Receivables for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$89.24M USD+37.3%+15.9%1.7%
GKOSGlaukos CorporationLTM Jun 2026$60.95M USD+79.6%+156.6%9.9%
STAASTAAR Surgical CompanyLTM Apr 2026$42.26M USD-270.2%—14.6%
ALCAlcon Inc.LTM Sep 2026$34.89M USD-77.2%-7.7%0.3%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$19.05M USD-355.9%+58.8%250.2%
RXSTRxSight, Inc.LTM Mar 2026$8.52M USD+190.0%—6.7%
SGHTSight Sciences, Inc.LTM Mar 2026$1.14M USD-118.2%—1.4%
OCULOcular Therapeutix, Inc.LTM Mar 2026$874K USD-34.0%—1.7%
OCSOculis Holding AGLTM Mar 2026CHF 272.05K CHF-142.6%—54.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$8K USD———
Peer median (excluding SGP) —-77.2%+37.4%6.7%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.